Business

Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US

Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US

articleImugene LtdJuly 19, 20234/company/imugene-ltd/news/imugene-oncolytic-virotherapy-cf33-patent-allowed-in-the-us
Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US

About this update from Imugene Ltd

[{"type":"text","content":"Imugene Ltd has released a press release. View Attachment","length":218,"tagName":"div"}]

More updates from Imugene Ltd